Age-Related Macular Degeneration treatment cost in New Taipei

Your first spend is the work-up, not the treatment — the typical items, priced from this registry where we hold them.

Consultation fees from our specialist registry; procedure prices from this condition's mapped diagnostics. Unverified prices are labeled on their own pages.

The same care market across the registry — cheapest entry first. Cheapest ≠ best: the MCI column grades each market as its data lands.

• Public-system wait at home (UK)NHS England referral-to-treatment statistics, Apr 2026 · Canada (CIHI) next 11.9-week median
• Recruiting age-related macular degeneration trials in TaiwanClinicalTrials.gov — recruiting studies with a Taiwan site Not yet sourced
• JCI-accredited organizations in TaiwanJCI public directory, country-wide (all specialties) Not yet sourced

Cheapest entry price per city with the size of its priced treatment menu and specialist density — countable signals only, "—" is never guessed.

The best hospitals first — Newsweek World's Best national top 10 lead, then our connected-chain grade. Re-rank by rating or reviews.

Epidemiology slots — filled only from named registry sources, never estimated.

Having your existing diagnosis re-read here is the cheapest way to test a hospital's quality before booking anything. Prices land per hospital with sources — never estimated.

• Remote records review — written second opinion your existing scans, pathology and reports, reviewed without flying Not yet priced
• Video consultation with a specialist live case discussion after the review Not yet priced
• In-person specialist consultation reference price if you're already here Not yet priced

A second opinion changes the plan often enough that specialists expect to be asked for one — it's a normal request, not an insult. Remote-review prices are being collected per hospital.

How the treatment decision is typically made for this condition — your specialist confirms the path for your case.

1. 1

   See the right specialist

   Care for age-related macular degeneration starts with a ophthalmologist, who confirms the diagnosis and plans the next steps.

2. 2

   Diagnosis & tests

   The diagnosis is confirmed with Comprehensive Eye Exam, OCT (Optical Coherence Tomography) or Fundus Photography.

3. 3

   Treatment options

   Options include Intravitreal Injections — weighed on outcome, downtime, risk and total cost. See the priced menu and decision factors below.

4. 4

   Treatment or management

   The chosen option is carried out or the condition is managed — every option below links to its own price page with a recovery timeline.

5. 5

   Follow-up & monitoring

   Check-ups confirm the result and adjust treatment; remote follow-up is common for international patients.

Framework pathway modeled by field — per-condition clinical pathways replace it as they're sourced.

What actually decides between the treatments above — and the checklist an expert would put to the specialist.

A planning frame — suitability is always the specialist's call.

What matters if it goes wrong, and what it takes to get there — country-level, verifiable guidance in one place.

Visa

Tiered visa-free entry by nationality (Bureau of Consular Affairs, BOCA): 90 days for ~57 countries (most of the EU, US, UK, Japan, South Korea, Australia, Canada, New Zealand, Israel and others); 30 days for Malaysia, Singapore and several Caribbean/Central American states; 14 days for Oman; a running trial 14-day visa-free scheme for Thailand, Brunei and the Philippines (through 2027-07-31). All other nationalities require a visa. British and Canadian nationals can extend their 90-day visa-free stay by a further 90 days (max 180 days total). Confirm your nationality's current rule before travelling.

Medical / long-stay visa

Taiwan has a DEDICATED short-term medical-treatment stay-visa ('外籍人士來台短期就醫申請停留簽證', BOCA's foreign-nationals stay-visa category #13), distinct from tourism/business visas — a materially stronger, more explicit medical-visa regime than Turkey's (which has none). Eligibility is gated on two conditions: the treated condition must be on MOHW's published list of diseases eligible for foreign/PRC-resident treatment in Taiwan, and treatment must be at one of MOHW's published 'International Medical Service Internationalization' member institutions (mostly in Taipei). Requirements: proof of funds or a payment agreement with the Taiwan institution, a diagnosis certificate from a foreign hospital, a treatment plan from the Taiwan institution, and a round-trip ticket. Up to 2 accompanying persons are allowed (spouse/relative within the 3rd degree, or 2 home-country medical staff); emergency medical visas can be filed directly by the Taiwan medical institution with BOCA.

Traveller safety

Very safe for visitors

Legal recourse

Established malpractice recourse

Insurance

Medical-travel & complication cover widely available

International patients

Hospitals accustomed to international patients

General guidance from public sources — confirm current rules for your nationality. Verified against: BOCA — Visa-exempt entry into Taiwan · BOCA — Short-term medical-treatment stay-visa.

Who treats age-related macular degeneration, and nearby diagnoses in the same field.

Dots carry the lens colors — teal opens a specialist page, red another condition, both priced for New Taipei.

How much of this page is verified data — every section carries a chip telling you where its numbers come from.